TLE1 and synovial sarcoma: Since all the cases showed TLE1 immunopositivity, effect modifier was kept under control via stratification with regards to age, gender, and type of SS to measure the outcome on TLE1 as strong positive, moderate/intermediate positive, and weak positive.